v4 Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-491
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
An Investigational Immunotherapy Study of BMS-986258 Alone and in Combination With Nivolumab in Participants With Solid Cancers That Are Advanced or Have Spread
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Experimental Medication BMS-986036 Given to Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Study of Nivolumab for Advanced Cancers in India
- Status
- COMPLETED
- Phase
- PHASE4
An Investigational Immunotherapy Study of BMS-986299 Alone and in Combination With Nivolumab and Ipilimumab in Participants With Solid Cancers That Have Spread or Cannot be Removed
- Status
- TERMINATED
- Phase
- PHASE1
PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib and Nivolumab in Treating Participants With Unresectable, Locally Advanced or Metastatic Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Survival Study for Participants Treated With Ipilimumab-Nivolumab Combination Therapy
- Status
- COMPLETED
- Phase
- N/A
Nivolumab Maintenance Therapy After Autologous Stem Cell Transplant in Hodgkin Lymphoma Pts at Relapse/Progression Risk
- Status
- COMPLETED
- Phase
- PHASE2
Stereotactic Body Radiotherapy (SBRT) Plus Immunotherapy for Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Combination Tumor Treating Fields (TTF; Optune), Nivolumab Plus/Minus Ipilimumab for Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Experimental Medication BMS-986278 Given to Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Real-World Observational Study for the Safety and Efficacy of Baraclude in Korean Pediatric Patients With Chronic Hepatitis B
- Status
- COMPLETED
- Phase
- N/A
Treatment Patterns in Advanced Small Cell Lung Cancer (SCLC)
- Status
- COMPLETED
- Phase
- N/A
Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Stage III or IV Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Biomarkers of Response to Ipilimumab and Nivolumab in First-line NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1
Nivolumab and RT in Treating Patients With Localized/Locally Advanced Urothelial Bladder Cancer Ineligible for Chemo
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE2